Rat Uterine Growth and Induction of Progesterone Receptor without Estrogen Receptor Translocation*
- 1 May 1985
- journal article
- research article
- Published by The Endocrine Society in Endocrinology
- Vol. 116 (5) , 1845-1857
- https://doi.org/10.1210/endo-116-5-1845
Abstract
The rat uterus responds to estradiol (E2) and E2 benzoate [E2B] stimulation with an increase in progesterone receptor production and with growth. These responses were also elicited to varying degrees by a series of estrogenic (ICI 77,949 [trans-1-(4-hydroxyphenyl)-1,2-diphenyl-but-2-ene] and ICI 47,699 [cis-1-(p-dimethylaminoethoxyphenyl)-1,2-diphenyl-2-ethylethylene]) and antiestrogenic triphenylethylene derivatives [tamoxifen (TAM), 4-hydroxy-TAM) (4-OH-TAM and 4-CH3-TAM]. These compounds have a range of affinities for the estrogen receptor (ER) and are able to compete with [3H]E2 binding in the uterus in vivo. Within 1-2 h of a s.c. injection of high affinity ligands (E2, E2B and 4-OH-TAM), there was a decrease in cytosol ER. This decrease was also observed with TAM, which is metabolized to 4-OH-TAM in vivo. There was no decrease in cytosolic ER in animals treated with low affinity compounds (ICI 77,949, ICI 47,699 and 4-CH3-TAM) at any time before the onset of an estrogen response. The nuclear ER increased after administration of a high affinity ligand (E2), as measured by exchange assay, but no increase in nuclear ER was observed after administration of low affinity ligands (ICI 77,949 and 4-CH3-TAM), although estrogenic responses were produced. A functional model was suggested to explain ER-mediated events in the rat uterus that supports the recent proposal that unoccupied ER is located in the nuclear compartment. In this model, the majority of unoccupied ER may reside in the nucleus in vivo; when the cells are disrupted in vitro, the unoccupied receptor or dissociation of low affinity ligand-ER complex causes unoccupied receptor to fall out of the nucleus and to be incorporated into the cytosolic fraction. The high affinity ligand-ER complexes are retained in the nucleus. The apparent translocation of the ER from the cytoplasm to the nucleus may be an artifact. The data may reflect differential extraction of unoccupied receptors from the nucleus rather than transfer of receptor complexes to the nucleus.This publication has 14 references indexed in Scilit:
- Hydroxylated metabolites of tamoxifen are formed in vivo and bound to estrogen receptor in target tissues.Journal of Biological Chemistry, 1981
- Biological Potency and Uterine Estrogen Receptor Interactions of the Metabolites of the Antiestrogens CI628 and U23,469*Endocrinology, 1981
- SUBCELLULAR EFFECTS OF MONOHYDROXYTAMOXIFEN IN THE RAT UTERUS: STEROID RECEPTORS AND MITOSISJournal of Endocrinology, 1980
- Subcellular compartmentalization of estrogen receptors in human breast cancer cellsExperimental Cell Research, 1980
- Nuclear mechanisms of estrogen action. Effects of estradiol and anti-estrogens on estrogen receptors and nuclear receptor processing.Journal of Biological Chemistry, 1978
- Actinomycin D prevents nuclear processing of estrogen receptor.Journal of Biological Chemistry, 1978
- Anti-estrogen interaction with uterine estrogen receptors. Studies with a radiolabeled anti-estrogen (CI-628).Journal of Biological Chemistry, 1978
- Estrogen receptor. Unoccupied sites in nuclei of a breast tumor cell line.Journal of Biological Chemistry, 1977
- Estrogen target cellsExperimental Cell Research, 1976
- HIGH RESOLUTION AUTORADIOGRAPHY WITH DRY MOUNTED, FREEZE-DRIED FROZEN SECTIONS COMPARATIVE STUDY OF SIX METHODS USING TWO DIFFUSIBLE COMPOUNDS H-ESTRADIOL AND H-MESOBILIRUBINOGENJournal of Histochemistry & Cytochemistry, 1966